165
Participants
Start Date
September 6, 2019
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
Venetoclax
oral; film-coated tablets or tablets for oral suspension
National Taiwan University Hospital /ID# 224946, Taipei City
Cliniques Universitaires UCL Saint-Luc /ID# 224327, Brussels
Aotearoa Clinical Trials /ID# 225596, Papatoetoe
Royal Prince Alfred Hospital /ID# 239557, Camperdown
Rigshospitalet /ID# 224213, Copenhagen Ø
Liverpool Hospital /ID# 225591, Liverpool
St George Hospital /ID# 225589, Kogarah
Peter MacCallum Cancer Ctr /ID# 210559, Melbourne
Perth Blood Institute Ltd /ID# 225592, Nedlands
Wellington Regional Hospital /ID# 225593, Newtown
Fiona Stanley Hospital /ID# 239480, Murdoch
Duplicate_Medizinische Universitaet Graz /ID# 223817, Graz
Aarhus Universitetshospital - Skejby /ID# 224214, Aarhus
General Hospital of Athens Laiko /ID# 224087, Athens
Hospital Universitario Fundacion Jimenez Diaz /ID# 225476, Madrid
Istanbul University Istanbul Medical Faculty /ID# 225045, Istanbul
Vehbi Koc vakfi Amerikan Hasta /ID# 225046, Istanbul
CHU Grenoble - Hopital Michallon /ID# 240497, La Tronche
China Medical University Hospital /ID# 224945, Taichung
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 231132, Ann Arbor
Municipal Non-Profit Enterprise City Clinical Hospital 4 of Dnipro City Council /ID# 240575, Dnipro
General Hospital of Thessaloniki George Papanikolaou /ID# 224088, Thessaloniki
Centro de Investigacion Clínica Chapultepec SA de CV /ID# 227018, Morelia
Ingalls Memorial Hosp /ID# 210553, Harvey
Hospital Universitario Dr. Jose Eleuterio Gonzalez /ID# 227017, Monterrey
HCL - Hopital Lyon Sud /ID# 213508, Pierre-Bénite
University of Arizona Cancer Center - Tucson /ID# 210548, Tucson
UCLA Santa Monica Hematology Oncology /ID# 210551, Los Angeles
Federal State Budgetary Scientific Institution N.N. Blokhin /ID# 225194, Moscow
Regional Oncological Dispensary /ID# 225195, Penza
Queen Mary Hospital /ID# 224944, Hong Kong
Dana-Farber Cancer Institute /ID# 215360, Boston
Dartmouth-Hitchcock Medical Center /ID# 210555, Lebanon
Swedish Cancer Institute /ID# 213120, Seattle
CHUQ- Hôpital de l'Enfant-Jesus /ID# 224616, Québec
Beaumont Hospital /ID# 225165, Dublin
Kobe City Medical Center General Hospital /ID# 241518, Kobe
Duplicate_National Hospital Organization Mito Medical Center /ID# 241986, Higashi Ibaraki-gun
Okayama Medical Center /ID# 241517, Okayama
National Cancer Center Hospital /ID# 241516, Chuo-ku
North Shore Hospital /ID# 225597, Takapuna
Duplicate_Pratia MCM Krakow /ID# 218561, Krakow
Instytut Hematologii i Transfuzjologii /ID# 225478, Warsaw
SP ZOZ Zespol Szpitali Miejskich w Chorzowie /ID# 225474, Chorzów
IPO Lisboa FG, EPE /ID# 225072, Lisbon
Samsung Medical Center /ID# 240882, Seoul
Duplicate_Skane University Hospital Lund /ID# 224747, Lund
Ankara Univ Medical Faculty /ID# 225043, Ankara
Derriford Hospital and the Royal Eye Infirmary /ID# 218731, Plymouth
Leicester Royal Infirmary /ID# 240468, Leicester
University College London Hospital /ID# 240467, London
University Hospital Southampton NHS Foundation Trust /ID# 225161, Southampton
Blackpool Teaching Hospitals NHS Foundation Trust /ID# 225163, Blackpool
Clatterbridge Cancer Centre - Liverpool /ID# 218736, Liverpool
King's College Hospital NHS Foundation Trust /ID# 218735, London
The Royal Wolverhampton NHS Trust /ID# 225164, Wolverhampton
Lead Sponsor
AbbVie
INDUSTRY